Loading…

Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T 1 and T 2 Mapping in a PET/MR Setting

Multiparametric magnetic resonance imaging (MRI) can be used to characterize many cancer subtypes including ovarian cancer. Quantitative mapping of MRI relaxation values, such as and mapping, is promising for improving tumor assessment beyond conventional qualitative - and -weighted images. However,...

Full description

Saved in:
Bibliographic Details
Published in:IEEE transactions on radiation and plasma medical sciences 2019-07, Vol.3 (4), p.509-515
Main Authors: Kaggie, Joshua D, Deen, Surrin, Kessler, Dimitri A, McLean, Mary A, Buonincontri, Guido, Schulte, Rolf F, Addley, Helen, Sala, Evis, Brenton, James, Graves, Martin J, Gallagher, Ferdia A
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Multiparametric magnetic resonance imaging (MRI) can be used to characterize many cancer subtypes including ovarian cancer. Quantitative mapping of MRI relaxation values, such as and mapping, is promising for improving tumor assessment beyond conventional qualitative - and -weighted images. However, quantitative MRI relaxation mapping methods often involve long scan times due to sequentially measuring many parameters. Magnetic resonance fingerprinting (MRF) is a new method that enables fast quantitative MRI by exploiting the transient signals caused by the variation of pseudorandom sequence parameters. These transient signals are then matched to a simulated dictionary of and values to create quantitative maps. The ability of MRF to simultaneously measure multiple parameters, could represent a new approach to characterizing cancer and assessing treatment response. This feasibility study investigates MRF for simultaneous , , and relative proton density (rPD) mapping using ovarian cancer as a model system.
ISSN:2469-7311
2469-7303
DOI:10.1109/TRPMS.2019.2905366